184 related articles for article (PubMed ID: 28914761)
1. Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes.
Bijak M; Dziedzic A; Synowiec E; Sliwinski T; Saluk-Bijak J
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28914761
[TBL] [Abstract][Full Text] [Related]
2. Flavonolignans inhibit the arachidonic acid pathway in blood platelets.
Bijak M; Saluk-Bijak J
BMC Complement Altern Med; 2017 Aug; 17(1):396. PubMed ID: 28797264
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets.
Bijak M; Szelenberger R; Dziedzic A; Saluk-Bijak J
Molecules; 2018 Feb; 23(2):. PubMed ID: 29439388
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models.
Bijak M; Synowiec E; Sitarek P; Sliwiński T; Saluk-Bijak J
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29240674
[TBL] [Abstract][Full Text] [Related]
5. Flavonolignans reduce the response of blood platelet to collagen.
Bijak M; Dziedzic A; Saluk-Bijak J
Int J Biol Macromol; 2018 Jan; 106():878-884. PubMed ID: 28842200
[TBL] [Abstract][Full Text] [Related]
6. Flavonolignans inhibit ADP induced blood platelets activation and aggregation in whole blood.
Bijak M; Szelenberger R; Saluk J; Nowak P
Int J Biol Macromol; 2017 Feb; 95():682-688. PubMed ID: 27923566
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo.
Pourová J; Applová L; Macáková K; Vopršalová M; Migkos T; Bentanachs R; Biedermann D; Petrásková L; Tvrdý V; Hrubša M; Karlíčková J; Křen V; Valentová K; Mladěnka P
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31554252
[TBL] [Abstract][Full Text] [Related]
8. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Albassam AA; Frye RF; Markowitz JS
Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
[TBL] [Abstract][Full Text] [Related]
9. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Int J Cancer; 2008 Jul; 123(1):41-50. PubMed ID: 18435416
[TBL] [Abstract][Full Text] [Related]
10. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Patrick KS; Markowitz JS
Drug Metab Dispos; 2013 Sep; 41(9):1679-85. PubMed ID: 23835761
[TBL] [Abstract][Full Text] [Related]
11. Identification of hepatoprotective flavonolignans from silymarin.
Polyak SJ; Morishima C; Lohmann V; Pal S; Lee DY; Liu Y; Graf TN; Oberlies NH
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5995-9. PubMed ID: 20231449
[TBL] [Abstract][Full Text] [Related]
12. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells.
Trappoliere M; Caligiuri A; Schmid M; Bertolani C; Failli P; Vizzutti F; Novo E; di Manzano C; Marra F; Loguercio C; Pinzani M
J Hepatol; 2009 Jun; 50(6):1102-11. PubMed ID: 19398228
[TBL] [Abstract][Full Text] [Related]
13. Chemotaxonomic and biosynthetic relationships between flavonolignans produced by Silybum marianum populations.
AbouZid SF; Ahmed HS; Moawad AS; Owis AI; Chen SN; Nachtergael A; McAlpine JB; Brent Friesen J; Pauli GF
Fitoterapia; 2017 Jun; 119():175-184. PubMed ID: 28392269
[TBL] [Abstract][Full Text] [Related]
14. Identification of UDP-glucuronosyltransferases involved in the metabolism of silymarin flavonolignans.
Vrba J; Papoušková B; Lněničková K; Kosina P; Křen V; Ulrichová J
J Pharm Biomed Anal; 2020 Jan; 178():112972. PubMed ID: 31727359
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the superoxide anion release and hydrogen peroxide formation in PMNLs by flavonolignans.
Varga Z; Czompa A; Kakuk G; Antus S
Phytother Res; 2001 Nov; 15(7):608-12. PubMed ID: 11746843
[TBL] [Abstract][Full Text] [Related]
16. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway.
Martinelli T; Whittaker A; Benedettelli S; Carboni A; Andrzejewska J
Phytochemistry; 2017 Dec; 144():9-18. PubMed ID: 28863306
[TBL] [Abstract][Full Text] [Related]
17. Flavonolignan 2,3-dehydroderivatives: Preparation, antiradical and cytoprotective activity.
Pyszková M; Biler M; Biedermann D; Valentová K; Kuzma M; Vrba J; Ulrichová J; Sokolová R; Mojović M; Popović-Bijelić A; Kubala M; Trouillas P; Křen V; Vacek J
Free Radic Biol Med; 2016 Jan; 90():114-25. PubMed ID: 26582372
[TBL] [Abstract][Full Text] [Related]
18. Flavonolignans from silymarin modulate antibiotic resistance and virulence in Staphylococcus aureus.
Holasová K; Křížkovská B; Hoang L; Dobiasová S; Lipov J; Macek T; Křen V; Valentová K; Ruml T; Viktorová J
Biomed Pharmacother; 2022 May; 149():112806. PubMed ID: 35303568
[TBL] [Abstract][Full Text] [Related]
19. Adhesive interaction between peripheral blood mononuclear cells and activated platelets in the presence of anti-human leukocyte antigen Class I alloantibody causes production of IL-1β and IL-8.
Takahashi D; Fujihara M; Azuma H; Wakamoto S; Sato S; Kato T; Ikeda H
Vox Sang; 2012 Apr; 102(3):250-7. PubMed ID: 21923858
[TBL] [Abstract][Full Text] [Related]
20. Glucosamine sulfate inhibits leukocyte adhesion in response to cytokine stimulation of retinal pigment epithelial cells in vitro.
Chen JT; Chen PL; Chang YH; Chien MW; Chen YH; Lu DW
Exp Eye Res; 2006 Nov; 83(5):1052-62. PubMed ID: 16822504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
